HOME >> MEDICINE >> NEWS
Three Harvard Medical School endowed chairs named simultaneously in sleep medicine

these chairs are leaders of an innovative industry that has a number of developing therapeutic tools and treatments in the pipeline. "There is a huge need for collaboration between industry and academic medicine to understand the relationship between sleep and disease," said Martin.

An esteemed professor was appointed to fill one of these chairs yesterday by the President and Fellows of Harvard College upon the recommendation of the Dean of the Faculty of Medicine and the trustees of the affiliated hospitals. Charles A. Czeisler, PhD, MD, has been named The Frank Baldino, Jr., PhD Professor of Sleep Medicine, which was the first of these chairs to be fully endowed, through a gift from Cephalon. Czeisler is a Harvard Medical School Professor of Medicine appointed in the Department of Medicine at the Brigham and Women's Hospital and leads the Division of Sleep Medicine.

" We at Cephalon are committed to helping the division continue its work in revolutionizing the field of sleep medicine. Dr. Czeisler and the team at Harvard Medical School are transforming the ways in which we think about sleep and wakefulness and are influencing the therapies being used to treat sleep disorders. We are proud to support the division by serving on its Executive Council and by taking the lead in establishing endowed professorships in sleep medicine," said Frank Baldino, Jr., PhD, Chairman & CEO of Cephalon.

Czeisler is energized about the implications of these endowments."The creation of these three endowed professorships in sleep medicine at HMS represents an important milestone for the field. The endowment of these three professorships serves to establish sleep medicine permanently within the framework of HMS. The fact that these are professorships of sleep medicine and not within an existing department highlights the interdisciplinary nature of this field and signifies that sleep medicine has finally come of age within academic medicine," he said. Czeisler is
'"/>

Contact: Judith Montminy
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
11-May-2004


Page: 1 2 3 4 5

Related medicine news :

1. Three-year cervical cancer screening recommendations may be applicable for certain women with HIV
2. Three anti-platelet drugs used in combination are safe
3. Three out of the four million newborn babies who die each year could be saved
4. Three-year health study of teenage girls is underway at Trenton Central High School
5. Three months is too soon to judge a CML patients response to Gleevec, researchers find
6. Three Abbott chemists honored as Heroes for development of HIV therapy for children
7. Three Pfizer Inc chemists win Heroes award for epilepsy treatment for children, adults
8. Three Merck chemists win Heroes of Chemistry award for major asthma treatment advance
9. Three-time Emmy Award winning actress Kathy Baker to participate in ADHD experts on call program
10. Three-month antibiotic treatment reduces risk of future heart attack
11. Irritable Bowel Syndrome The Focus Of Three UNC-CH Reports At Digestive Diseases Conference

Post Your Comments:
(Date:5/25/2013)... 25, 2013 On May 20, 2013 the ... not wish to discuss or plan for their eventual demise, ... FuneralFinancials.com released a Must-Do List to help people properly ... recommends, “Creating a personal fact sheet.” , While not a ... information and personal data. It may include a summary ...
(Date:5/25/2013)... 2013 The latest report from ... bowel syndrome (IBS) to bloating, constipation, diarrhea and ... long-lasting, embarrassing, frustrating and difficult health issues to ... health have provided a cure for these ... contributing to digestive health issues, a healthy diet ...
(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
(Date:5/25/2013)... May 25, 2013 Many orthodontists have ... wonder where exactly that cloud is. Most people ... up with to provide their cloud service and support ... provide the service they're selling, they'd be wrong. ... (a secure, redundant facility that houses servers and ...
(Date:5/25/2013)... May 25, 2013 According to world-renowned ... beautiful and powerful women that ever lived. Cleopatra’s legendary ... some of the most powerful men in her time. ... remedies to keep her skin glowing and fresh, from ... bees- wax, maringa oil and cyprus grass. , Cleopatra ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
(Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...
(Date:5/23/2013)... THOUSAND OAKS, Calif. , May 23, 2013 ... Deutsche Bank 38 th Annual  Healthcare Conference on Thursday, ... Boston , beginning at 9:20 a.m. Eastern Daylight ... Investor Relations at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
(Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
Cached News: